US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 24.290
  • -0.640-2.57%
Close May 10 16:00 ET
  • 24.000
  • -0.290-1.19%
Post 19:23 ET
712.90MMarket Cap-8264P/E (TTM)

About Dianthus Therapeutics Company

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.

Company Profile

SymbolDNTH
Company NameDianthus Therapeutics
Listing DateJun 21, 2018
Founded2015
CEOMr. Marino Garcia
MarketNASDAQ
Employees53
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address7 Times Square,43rd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-929-999-4055
Websitehttp://dianthustx.com

Company Executives

  • Name
  • Position
  • Salary
  • Marino Garcia
  • President, Chief Executive Officer and Director
  • --
  • Ryan Savitz
  • Chief Financial Officer and Chief Business Officer
  • --
  • Edward G. Carr
  • Chief Accounting Officer
  • --
  • Dr. Simrat Randhawa, M.D.
  • Chief Medical Officer
  • --
  • Leon O. Moulder, Jr
  • Chairman of the Board
  • --
  • Dr. Jonathan Violin, M.B.A.,PhD
  • Director
  • --
  • Lei Meng
  • Director
  • --
  • Alison F. Lawton
  • Independent Director
  • --
  • Tomas Kiselak
  • Independent Director
  • --
  • Paula Soteropoulos
  • Independent Director
  • --
  • Anne M. McGeorge
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg